Purpose: To investigate the molecular mechanisms that lead to inhibition of intimal hyperplasia (IH) following p53 gene therapy. Methods: In vivo p53 gene transfer to balloon injured rat carotid arteries was performed by utilizing adenovirus. The relationship between p53, p21, retinoblastoma protein (Rb), B-cell lymphoma 2 (Bcl-2), Bax, and Bcl-x was examined by immunohistochemistry. Expression of cyclin D1, Fas/CD95, and poly(ADP-ribose)polymerase (PARP) was determined. Results: Our data indicate increased expression of p53 in the nuclei of vascular smooth muscle cells (VSMCs) in the media (P < .01) compared with the controls. In the treated animals, Bax and Bcl-x, p21, and Rb were significantly upregulated (P < .01). Immunoreactivity to Bcl-2 was observed only in the neointima of untreated groups at 14 days. An increased presence of Fas and decreased expression of PARP was observed in the cytoplasm of the VSMCs of p53-treated animals. Conclusions: P53 gene transfer activated a battery of downstream effector genes whose products are directly involved in cell cycle arrest, DNA repair, and apoptosis.
FergusonJE3rdPattersonC.Break the cycle: the role of cell-cycle modulation in the prevention of vasculoproliferative diseases. Cell Cycle. 2003;2(3):211–219.
2.
KatayoseDWerstoRCowanKSethP.Consequences of p53 gene expression by adenovirus vector on cell cycle arrest and apoptosis in human aortic vascular smooth muscle cells. Biochem Biophys Res Commun. 1995;215(2):446–451.
3.
LangFFBrunerJMFullerGN. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol. 2003;21(13):2508–2518.
4.
SwisherSGRothJAKomakiR. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res. 2003;9(1):93–101.
5.
SwisherSGRothJA.Clinical update of Ad-p53 gene therapy for lung cancer. Surg Oncol Clin N Am. 2002;11(3):521–535.
6.
PagliaroLCKeyhaniAWilliamsD. Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy. J Clin Oncol. 2003;21(12):2247–2253.
7.
ScheinmanMAscherELeviGSHingoraniAShirazianDSethP.P53 gene transfer to the injured rat carotid artery decreases neointimal formation. J Vasc Surg. 1999;29(2):360–369.
8.
ScheinmanMAscherEKallakuriS. P53 gene transfer to the injured rat carotid artery promotes apoptosis. Surgery. 1999;126(5):863–868.
9.
ScheinmanMAscherEHingoraniASethPMarellaVKJacobT.Effect of p53 gene therapy combined with CTLA4Ig selective immunosuppression on prolonged neointima formation reduction in a rat model. Ann Vasc Surg. 2000;14(4):385–392.
10.
YonemitsuYKanedaYTanakaS. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res. 1998;82(2):147–156.
11.
GeorgeSJAngeliniGDCapogrossiMCBakerAH.Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis. Gene Ther. 2001;8(9):668–676.
PalmqvistRStenlingRObergALandbergG.Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer. 1998;34(10):1575–1581.
14.
TannerFCYangZYDuckersEGordonDNabelGJNabelEG.Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res. 1998;82(3):396–403.
15.
HuangHJYeeJKShewJY. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science. 1988;242(4885):1563–1566.
16.
BukholmIKBernerJMNeslandJMBørresen-DaleAL.Expression of cyclin Ds in relation to p53 status in human breast carcinomas. Virchows Arch. 1998;433(3):223–228.
17.
SongJMKimHSRheeMY. Effect of hypercholesterolemia on the sequential changes of apoptosis and proliferation after balloon injury to rabbit iliac artery. Atherosclerosis. 2000;150(2):309–320.
18.
OltavaiZNMillimanCLKorsmeyerSJ.Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74(4):609–619.
19.
SatohMSLindahlT.Role of poly(ADP-ribose) formation in DNA repair. Nature. 1992;356(6367):356–358.
20.
TewariMQuanLTORourkeK. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995;81(5):801–809.
21.
NicholsonDWAliAThornberryNA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376(6535):37–43.
22.
KatayoseDGudasJNguyenHSrivastavaSCowanKHSethP.Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin Cancer Res. 1995;1(8):889–897.
23.
MullerDW.The role of proto-oncogenes in coronary restenosis. Prog Cardiovasc Dis. 1997;40(2):117–128.
24.
Diaz-SandovalLJLosordoDW.Gene therapy for cardiovascular angiogenesis. Expert Opin Biol Ther. 2003;3(4):599–616.
25.
AokiMMorishitaRMatsushitaH. Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth. Hypertension. 1999;34(2):192–200.
26.
ScottSO'SullivanMHafiziSShapiroLMBennettMR.Human vascular smooth muscle cells from restenosis or in-stent stenosis sites demonstrate enhanced responses to p53: implications for brachytherapy and drug treatment for restenosis. Circ Res. 2002;90(4):398–404.
27.
BaiHMorishitaRKidaI. Inhibition of intimal hyperplasia after vein grafting by in vivo transfer of human senescent cell-derived inhibitor-1 gene. Gene Ther. 1998;5(6):761–769.
28.
TakagiY.Adenovirus-mediated overexpression of a cyclin-dependent kinase inhibitor, p57Kip2, suppressed vascular smooth muscle cell proliferation. Hokkaido Igaku Zasshi. 2002;77(3):221–230.
29.
LandbergGNielsenNHNilssonPEmdinSOCajanderJRoosG.Telomerase activity is associated with cell cycle degeneration in human breast cancer. Cancer Res. 1997;57(3):549–554.
30.
ArberMHibshooshHMossSF. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology. 1996;110(3):669–674.
31.
JacobTAscherEHingoraniAKallakuriS.Effect of Von Hippel-Lindau gene transfer on human vascular smooth muscle cell proliferation and apoptosis. Vasc Endovasc Surg. 2004;39(1):25–32.
32.
JacobTAscherEHingoraniAGunduzYYorkovichWSethP.Von Hippel-Lindau gene therapy: a novel strategy in limiting endothelial cell proliferative activity. Ann Vasc Surg. 2001;15(1):1–6.
33.
LeeSWTrapnellBCRadeJJVirmaniRDichekDA.In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res. 1993;73(5):797–807.
34.
ChangMWBarrELuMMBartonKLeidenJM.Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest. 1995;96(5):2260–2268.
